Insecticides India Board Approves FY26 Audited Results, New ESPS Scheme
Insecticides (India) Limited approved audited financial results for FY26 and Q4FY26. The Board also approved the formulation of the Employee Stock Purchase Scheme 2026, offering up to 2,00,000 equity shares, subject to shareholder approval. Mrs. Nikunj Aggarwal resigned as Whole Time Director, and Mr. Sanskar Aggarwal was appointed as Additional Whole Time Director.
The approval of audited financial results is a routine event. However, the formulation of an Employee Stock Purchase Scheme and changes in key management personnel (resignation and appointment of Directors) can have a medium-term impact on the company's governance, employee motivation, and strategic direction.
The announcement includes the approval of audited financial results, which is routine. The formulation of an ESPS scheme and management changes are also standard corporate actions. While there's a resignation, it's stated to be without other material reasons. Overall, the news does not contain significantly positive or negative material information.
Insecticides (India) Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the Audited Financial Results for the Quarter and Year ended March 31, 2026, along with the Auditor's Report. The financial results were based on an unmodified opinion from the joint statutory auditors, M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co.
The Board also approved the formulation of the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme 2026), recommending the issuance of up to 2,00,000 equity shares. This scheme is subject to shareholder approval at the upcoming 29th Annual General Meeting (AGM).
In terms of personnel changes, the Board took note of the resignation of Mrs. Nikunj Aggarwal as Whole Time Director with immediate effect. Subsequently, Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director for a term of five years, effective May 28, 2026, subject to shareholder approval. The company also appointed Mr. Atul Kumar as Vice President - Sales (North), a Senior Management Personnel, effective May 28, 2026. Furthermore, M/s. T Jain & Associates were appointed as the Internal Auditor for a five-year term from April 1, 2026, to March 31, 2031.
The 29th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing.
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.